Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318341 · ClinicalTrials.gov registry record · NA
TheraBracelet Phase I
A NA study of Stroke and Cerebrovascular Accident, sponsored by TheraBracelet.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03318341: Completed NA study of Stroke and Cerebrovascular Accident, sponsored by TheraBracelet.
NCT03318341 is a NA study of Stroke and Cerebrovascular Accident that has completed, run by TheraBracelet. The registered enrollment target is 26 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03318341, a NA study of Stroke and Cerebrovascular Accident, has completed, sponsored by TheraBracelet.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to test a new technology that may improve hand function impaired from a stroke, thereby improving independence and quality of life.
Primary Outcome
Any worsening of hand sensation, dexterity, grip strength, upper limb pain, swelling, spasticity, skin irritation, or any other adverse events (assessed every week) that sustained until the end of the month or occurred at the end of the month.
Conditions Studied
Interventions
- DEVICE Sham Stimulation
- DEVICE Real Stimulation
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2018-11-28 |
| Phase | NA |
What the finished NCT03318341 record still lists
NCT03318341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Sham Stimulation is the first listed.
NCT03318341 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT03318341 about?
NCT03318341 is a clinical study titled "TheraBracelet Phase I". This project aims to test a new technology that may improve hand function impaired from a stroke, thereby improving independence and quality of life.
What is the current status of trial NCT03318341?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-01-09. Estimated completion is 2018-11-28.
What conditions does trial NCT03318341 study?
This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident, Hemiparesis, Stroke Rehabilitation, Hand Function.
What interventions are being tested in trial NCT03318341?
The interventions under investigation include: Sham Stimulation (DEVICE), Real Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03318341?
This trial is sponsored by TheraBracelet, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03318341 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03318341's enrollment target sits among peer trials
26 325th of 454 higher than 129 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI